170 related articles for article (PubMed ID: 32933107)
1. Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer.
Capone F; Polo A; Sorice A; Budillon A; Costantini S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933107
[TBL] [Abstract][Full Text] [Related]
2. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model.
Diwadkar-Navsariwala V; Prins GS; Swanson SM; Birch LA; Ray VH; Hedayat S; Lantvit DL; Diamond AM
Proc Natl Acad Sci U S A; 2006 May; 103(21):8179-84. PubMed ID: 16690748
[TBL] [Abstract][Full Text] [Related]
3. Selenoproteins of the Human Prostate: Unusual Properties and Role in Cancer Etiology.
Diamond AM
Biol Trace Elem Res; 2019 Nov; 192(1):51-59. PubMed ID: 31300958
[TBL] [Abstract][Full Text] [Related]
4. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
Ekoue DN; Ansong E; Liu L; Macias V; Deaton R; Lacher C; Picklo M; Nonn L; Gann PH; Kajdacsy-Balla A; Prins GS; Freeman VL; Diamond AM
Prostate; 2018 Mar; 78(4):279-288. PubMed ID: 29314169
[TBL] [Abstract][Full Text] [Related]
5. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
6. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
7. Loss of SELENOF Induces the Transformed Phenotype in Human Immortalized Prostate Epithelial Cells.
Hong LK; Kadkol S; Sverdlov M; Kastrati I; Elhodaky M; Deaton R; Sfanos KS; Wang H; Liu L; Diamond AM
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769469
[TBL] [Abstract][Full Text] [Related]
8. Expression of Selenoprotein Genes and Association with Selenium Status in Colorectal Adenoma and Colorectal Cancer.
Hughes DJ; Kunická T; Schomburg L; Liška V; Swan N; Souček P
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30469315
[TBL] [Abstract][Full Text] [Related]
9. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
Bennett NC; Hooper JD; Johnson DW; Gobe GC
Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
12. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Expression and Prognostic Value of Selenoprotein Genes in Thyroid Cancer.
Zhao Y; Chen P; Lv HJ; Wu Y; Liu S; Deng X; Shi B; Fu J
Genet Test Mol Biomarkers; 2022 Apr; 26(4):159-173. PubMed ID: 35481968
[No Abstract] [Full Text] [Related]
14. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
15. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
18. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
Maria McCrohan A; Morrissey C; O'Keane C; Mulligan N; Watson C; Smith J; Fitzpatrick JM; Watson RW
Cancer; 2006 Jun; 106(12):2743-52. PubMed ID: 16703599
[TBL] [Abstract][Full Text] [Related]
19. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
Kim HJ; Park YI; Dong MS
Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
